title: Nocardiosis in a renal transplant recipient following rituximab preconditioning.
authors.forename: Tanya R
authors.initials: TR
authors.lastname: Flohr
authors.forename: Costi D
authors.initials: CD
authors.lastname: Sifri
authors.forename: Kenneth L
authors.initials: KL
authors.lastname: Brayman
authors.forename: Klaus D
authors.initials: KD
authors.lastname: Hagspiel
authors.forename: Robert G
authors.initials: RG
authors.lastname: Sawyer
authors.forename: Timothy L
authors.initials: TL
authors.lastname: Pruett
authors.forename: Hugo J R
authors.initials: HJ
authors.lastname: Bonatti
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016030:Kidney Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D009617:Nocardia Infections / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D019172:Transplantation Conditioning
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab